Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis

Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis

Abstract Background Although antifibrotic drugs, including nintedanib and pirfenidone, slow the progression of idiopathic pulmonary fibrosis (IPF), there is little data about the timing of start of antifibrotic treatment in real-world clinical practice. The present study aimed to clarify the efficac...

Full description

Bibliographic Details
Main Authors: Keishi Sugino, Hirotaka Ono, Natsumi Watanabe, Masahiro Ando, Eiyasu Tsuboi, Sakae Homma, Kazuma Kishi
Format: Article
Language:English
Published: BMC 2021-07-01
Series:BMC Pulmonary Medicine
Subjects:
Antifibrotic drug
Desaturation
GAP staging
Idiopathic pulmonary fibrosis
Prognosis
Online Access:https://doi.org/10.1186/s12890-021-01595-3

Internet

https://doi.org/10.1186/s12890-021-01595-3

Similar Items